Healthcare - Biotechnology - NASDAQ - US
$ 18.57
-13.3 %
$ 2.31 B
Market Cap
-3.99
P/E
INCOME STATEMENT
241 M
REVENUE
-205 M
OPERATING INCOME
-209 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Arrowhead Pharmaceuticals, Inc.
| Revenue | 241 M |
| Cost Of Revenue | 0 |
| Gross Profit | 241 M |
| Operating Expenses | 446 M |
| Operating Income | -205 M |
| Other Expenses | 4.27 M |
| Net Income | -209 M |
Income Statement
Millions
| Sep-2023 | Sep-2022 | Sep-2021 | Sep-2020 | Sep-2019 | Sep-2018 | Sep-2017 | Sep-2016 | Sep-2015 | Sep-2014 | Sep-2013 | Sep-2012 | Sep-2011 | Sep-2010 | Sep-2009 | Sep-2008 | Sep-2007 | Sep-2006 | Sep-2005 | Sep-2004 | Sep-2003 | Sep-2002 | Sep-2001 | Sep-2000 | Sep-1999 | Sep-1998 | Sep-1997 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | |||||||||||||||||||||||||||
| Revenue | 240.7 | 243.2 | 138.3 | 88.0 | 168.8 | 16.1 | 31.4 | 0.2 | 0.4 | 0.2 | 0.3 | 0.1 | 0.3 | 0.6 | 3.8 | 1.3 | 1.2 | 0.6 | 0.6 | 0.2 | 0 | 2.27 K | 9.31 K | 24.9 K | 37 K | 60.4 K | 76.6 K |
| GROSS PROFIT | |||||||||||||||||||||||||||
| Cost Of Revenue | 0 | 10.4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.7 | 0 | 0 | 0 | 0 | 87 | 6.3 K | 2.09 K | 2.85 K | 33.8 K | 37 K |
| Gross Profit | 240.7 | 232.8 | 138.3 | 88.0 | 168.8 | 16.1 | 31.4 | 0.2 | 0.4 | 0.2 | 0.3 | 0.1 | 0.3 | 0.6 | 3.8 | 1.3 | 0.5 | 0.6 | 0.6 | 0.2 | 0 | 2.18 K | 3.02 K | 22.8 K | 34.1 K | 26.6 K | 39.6 K |
| OPERATING INCOME | |||||||||||||||||||||||||||
| Operating Expenses | 445.7 | 421.7 | 287.3 | 181.2 | 107.6 | 72.1 | 68.4 | 79.9 | 96.4 | 51.3 | 23.6 | 21.2 | 10.1 | 9.4 | 23.5 | 36.3 | 38.4 | 21.8 | 10.0 | 3.0 | 94.4 K | 1.4 | 0.1 | 0.1 | 90.4 K | 68.9 K | 0.2 |
| Selling, General and Administrative Expenses | 90.9 | 124.4 | 81.0 | 52.3 | 26.6 | 19.1 | 32.0 | 41.0 | 34.7 | 24.4 | 11.7 | 14.1 | 5.2 | 8.0 | 14.1 | 23.8 | 17.1 | 12.3 | 6.0 | 2.2 | 91.1 K | 0.1 | 0.1 | 0.1 | 90.4 K | 50.6 K | 89.8 K |
| Research and Development Expenses | 353.2 | 297.3 | 206.3 | 128.9 | 81.0 | 53.0 | 31.7 | 41.5 | 57.4 | 23.1 | 8.7 | 5.4 | 3.3 | 1.1 | 9.0 | 12.1 | 20.9 | 8.6 | 3.8 | 0.8 | 3.38 K | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | (205.0) | (178.5) | (149.0) | (93.2) | 61.2 | (55.9) | (37.0) | (81.7) | (96.0) | (53.3) | (24.6) | (21.1) | (9.8) | (8.8) | (19.7) | (35.0) | (37.9) | (21.2) | (9.4) | (2.8) | 94.4 K | (1.4) | (0.1) | (0.1) | 56.2 K | 42.3 K | (0.2) |
| PRE-TAX INCOME | |||||||||||||||||||||||||||
| Interest Income Expense | 18.3 | 5.0 | 6.1 | 9 190.5 | 6 957.8 | 1 048.5 | 415.1 | 265.8 | 729.2 | 645.5 | 0 | 36.0 | 86.5 | 0 | 0.2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income | (1.5) | 5.8 | 8.2 | 8.6 | 7.0 | 1.5 | 2.6 | 22.1 K | 4.0 | (5.4) | (7.1) | (1.0) | 1.0 | 1.4 | (1.9) | (2.7) | (8.3) | 0.2 | 2.8 | 0.3 | 0 | 1.2 | 79.6 K | 28.3 K | (0.3) | (0.1) | (0.7) |
| Pre-Tax Income | (206.5) | (172.7) | (140.8) | (84.6) | 68.1 | (54.4) | (34.4) | (81.7) | (91.9) | (58.7) | (31.7) | (22.1) | (8.8) | (7.3) | (19.2) | (35.1) | (37.9) | (21.9) | (7.0) | (2.5) | 94.4 K | (0.2) | (0.2) | (0.1) | (0.4) | 10.5 K | (0.9) |
| NET INCOME | |||||||||||||||||||||||||||
| Tax Provision | 2.8 | 3.8 | 2 K | 2.4 K | 0.2 | 2.4 K | 2.4 K | 2.4 K | 2.4 K | 5.3 K | 6.2 | (0.2) | (6.9) | (3.2) | 54 K | (8.0) | (8.0) | (2.2) | (2.7) | 800 | 800 | (1.2) | 79.6 K | 28.3 K | (0.6) | 9.32 K | 0.7 |
| Net Income | (205.3) | (176.5) | (140.8) | (84.6) | 68.0 | (54.5) | (34.4) | (81.7) | (91.9) | (58.6) | (31.1) | (21.1) | (3.1) | (5.8) | (19.3) | (27.1) | (29.9) | (19.0) | (6.6) | (2.5) | 95.2 K | (0.2) | (0.2) | (0.1) | 0.6 | 51.6 K | (0.9) |
| EPS | 1.91 | 1.67 | 1.36 | 0.84 | 0.72 | 0.65 | 0.47 | 1.34 | 1.6 | 1.25 | 1.3 | 1.9 | 0.44 | 0.9 | 4.27 | 6.91 | 8.35 | 5.95 | 2.61 | 1.88 | 0.25 | 32.5 | 26 | 19.5 | 97.4 | 10.2 | 175 |